- Looking to the past eradication of diseases, a new paper argues that the global eradication of COVID-19 is possible.
- The paper quantifies the factors affecting eradicability and scores a few diseases accordingly.
- The authors of the paper hope and believe that the international disruption that COVID-19 has caused may drive the world’s governments toward a global solution.
As wealthier nations struggle to get more people to undergo vaccination, lower income nations struggle to acquire sufficient vaccine doses, and new SARS-CoV-2 variants emerge, a newly published paper states that the global eradication of COVID-19 remains possible nonetheless.
Lead author of the paper, Dr. Nick Wilson of the University of Otago in Wellington, New Zealand, pointed out to Medical News Today that skepticism regarding the paper’s conclusion is not surprising:
“[The] reaction is completely understandable at the current point in time, [but] when the plans to eradicate smallpox were announced, and there were still millions of cases globally per year, many people were also very skeptical.”
The paper cites the globally felt disruption resulting from COVID-19 as presenting an opportunity for a concerted international effort. Critical to an eradication program’s success is establishing strong vaccine coverage and staying ahead of rapidly developing variants.
The paper — entitled, “We should not dismiss the possibility of eradicating COVID-19: Comparisons with smallpox and polio” — appears in BMJ Global Health.
The metrics of optimism
The authors of the paper define eradications as the “permanent reduction to zero of the worldwide incidence of infection caused by a specific agent as a result of deliberate efforts; intervention measures are no longer needed.”
The paper presents a preliminary assessment of the eradicability of COVID-19 by comparing it with other worldwide diseases, including smallpox, which has been eradicated, and polio, for which just one of three serotypes persists.
Based on an established scoring system and additional technical, sociopolitical, and economic factors that the authors included, the study compiled a total of 17 variables relating to vaccine-preventable diseases, with a three-point relative scale for each variable. Each of the diseases received a score according to these metrics, with higher values indicating a greater chance of eradication.
COVID-19 scored as being slightly more eradicable than polio.
Smallpox was most eradicable with a score of 2.7. In comparison, COVID-19 scored 1.6, and polio scored 1.5.
Medical challenges
Dr. Robert Kim-Farley, MPH, of the University of California, Los Angeles’s Fielding School of Public Health — who was not involved in writing the article — told MNT: “The single greatest obstacle to true eradication will be achieving and sustaining the very high vaccination coverage (using a vaccine with no or extremely low infection breakthrough) needed to achieve full herd immunity, whereby transmission of COVID-19 in a community ceases.”
Although he is not giving up on achieving higher vaccination coverage through more robust international public health and social measures, Dr. Wilson said that herd immunity is not a requirement for eradication.
“Smallpox was eradicated without achieving herd immunity,” said Dr. Wilson, “but rather by targeted vaccination approaches. It is also notable that countries have also eliminated measles without (quite) achieving herd immunity, and, in fact, the whole of the Americas eliminated measles for a time.”
The paper notes that there is also a “risk of the persistence of the pandemic virus in non-human animal reservoirs,” a phenomenon that is occurring with COVID-19 in the U.S. and elsewhere.
Asked whether current animal reservoirs may doom an eradication effort, Dr. Wilson said we are not there yet.
“If we had the situation of influenza viruses (widespread in wild birds) then obviously eradication would not be feasible,” he noted.
He added that “it is possible to eradicate diseases in some wild animals — for example, eliminating rabies in wild foxes via aerial bait drops containing vaccine (as per Western Europe).”
Dr. Kim-Farley cited what he sees as the three most significant obstacles to eradication success.
Current vaccines, noted Dr. Kim-Farley, “although offering excellent protection against severe illness and death, still have some breakthrough infections that can infect others.”
Identifying cases of often-asymptomatic COVID-19 is also harder, said Dr. Kim-Farley, than it is with smallpox and measles, which “are usually always symptomatic and identifiable.”
Finally, there is “the lack of political will to apply (and the unwillingness of some persons to accept) the strict public health measures, such as required vaccination, required mask wearing, required quarantine and isolation, and required testing.”
News
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]















